Boston Scientific (BSX) Tops Q4 EPS by 4c, Beats on Revenue; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Boston Scientific (BSX) jumps as Q4 results exceed analyst expectations
January 31, 2024 6:39 AM ESTBoston Scientific (NYSE: BSX) reported stronger-than-expected results for its fourth quarter, sending its shares 4.3% higher in early New York trading Wednesday.
The company posted adjusted earnings per share (EPS) for the fourth quarter of 55 cents compared to 45 cents year-over-year (YoY), and beating the consensus estimate of 51... More
